MEG3 and neoplasm: Overexpression of MEG3 inhibited tumorigenesis in vivo and reduced NSCLC cell proliferation, as well as induced apoptosis in vitro, suggesting that delivery of tumor suppressor lncRNAs such as MEG3 may potentially be an alternative therapeutic option in NSCLC (Table 3) [137].